Atrial Fibrillation (AFib) is the most common sustained arrhythmia, which increases stroke risk five-fold, and accounts for almost one-third of all strokes. In the U.S. alone, AFib is responsible for approximately 130,000 deaths and 750,000 hospitalizations every year....
Abbott ($ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology...
Medtronic just launched one of the cooler medical device applications in an effort to help patients' pacemakers and mobile devices communicate with one another....
From CNET Magazine: Medical advances can keep the tiniest hearts beating.https://t.co/jPDCujs7Jx
— CNET News (@CNETNews) January 15, 2019
We first caught wind of the FDA clearance for the TransEnterix Ultrasonic System via the TRXC Stock Group on Facebook and now TransEnterix shared an official announcement this morning....
Titan Medical ($TMDI) announced that a peer-reviewed multi-faculty paper featuring Titan’s single-port platform has been published in the January 2019 issue of Surgical Endoscopy. The paper highlights the feasibility, safety and ease of use of Titan’s single-port robotic technology for general surgery procedures and is available here....
Olympus recently announced a plan to develop the company into a truly global medical technology company. The transformation plan is called, “Transform Olympus”, and will start April 1, 2019....
Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, launched one of the most wide-ranging investigations in decades into the prescription drug industry’s pricing practices....
Shares of Medtronic fell 6.5% after Medtronic CEO, Omar Ishrak, said during a presentation at the J.P. Morgan Healthcare Conference that sales would fall at the mid-point of the company's yearly projections due to softness in their cardiac and vascular divisions....
On the first day of the J.P. Morgan Healthcare Conference, Amgen announced they would lower the list price of monthly doses for their cholesterol lowering medicine Repatha by 60%. ...